NGM Biopharmaceuticals Obtains $51,000,000 Series B Funding Round

  • Feed Type
  • Date
    3/15/2010
  • Company Name
    NGM Biopharmaceuticals
  • Mailing Address
    630 Gateway Blvd South San Francisco, CA 94080-7014
  • Company Description
    The company is focused on developing treatments for metabolic diseases.
  • Website
    http://www.ngmbio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $51,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    The Column Group
  • Venture Investor
    Tichenor Ventures
  • Venture Investor
    Prospect Venture Partners
  • Venture Investor
    Rho Ventures

Trending on Xconomy